Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Pressurized Intraperitoneal Chemotherapy in High-Risk Colon Cancer
2017-002637-37Phase 2Active
- Sponsor
- University Hospital Odense
- Start
- Jun 2017
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of oxaliplatin in colon cancer and peritoneal carcinomatosis (PC), sponsored by University Hospital Odense. Primary endpoints: Peritoneal recurrence rate at 36 months, Change in peritoneal lavage cytology and 1 more. Started Jun 2017; status: active.
02
Drugs
oxaliplatin
03
Conditions
colon cancerperitoneal carcinomatosis (PC)
Beyond the preview
Go deeper on 2017-002637-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002637-37.